1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Riboflavin (vitamin B2) |
| brand | String | Many generics/OTC |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Vitamins|Vitamin]] • [[:Category:B-vitamins|B-vitamin]] |
| mechanism | String | '"`UNIQ--vote-0000124C-QINU`"' The 400 mg/d dose for migraine prophylaxis is supported by randomized trials (Schoenen 1998) and remains a low-risk evidence-based supplement option. Characteristic bright-yellow urine fluorescence with high-dose oral supplementation. |
| uses | String | '"`UNIQ--vote-0000124D-QINU`"', '"`UNIQ--vote-0000124E-QINU`"', '"`UNIQ--vote-0000124F-QINU`"' |
| starting_dose | String | Migraine prophylaxis: 400 mg PO daily; deficiency replacement 5-30 mg/d |
| preparations | String | 25, 50, 100, 250, 400 mg tablets; OTC |
| fda_max | String | No strict ceiling for water-soluble vitamin; UL not set |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV (rare) |
| onset | String | Migraine effect after 1-3 months of daily use |
| duration | String | N/A |
| halflife | String | ~1-2 hours plasma (riboflavin itself); FAD/FMN tissue cofactors are continuous |
| bioavailability | String | ~50-60% (oral; food enhances) |
| pregnancy | String | Safe at replacement and supplement doses.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | OTC in US |
